Related Experiment Video
Updated: May 17, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Topical intraocular pressure therapy effects on pregnancy
Carmen Mendez-Hernandez1, Julian Garcia-Feijoo, Federico Saenz-Frances
1Ophthalmology Department, Hospital Clinico San Carlos de Madrid, Madrid, Spain.
Clinical Ophthalmology (Auckland, N.Z.)
|October 31, 2012
Summary
Most pregnant glaucoma patients maintained stable intraocular pressure (IOP) and visual fields without disease progression. Medication use decreased, but one case showed delayed intrauterine growth with specific treatment.
Area of Science:
- Ophthalmology
- Reproductive Medicine
- Pharmacology
Background:
- Glaucoma management during pregnancy presents challenges due to potential risks to both mother and fetus.
- Understanding the impact of pregnancy on intraocular pressure (IOP) and glaucoma progression is crucial for effective treatment.
- Assessing the safety and efficacy of antiglaucoma medications in pregnant individuals is essential.
Observation:
- A study examined eight patients with glaucoma throughout their pregnancies.
- Intraocular pressure (IOP) and visual field indices (VFI) were monitored.
- The number of antiglaucoma medications required decreased during pregnancy.
Findings:
- No significant changes in IOP or VFI were observed in most patients (87.5%).
- A reduction in the mean number of glaucoma treatments was noted during the second and third trimesters.
- One patient on fixed combination timolol-dorzolamide experienced delayed intrauterine growth; no other adverse effects were reported.
Implications:
- Most pregnant individuals with glaucoma can maintain stable eye health with reduced medication.
- Careful monitoring is necessary, particularly for patients on specific combination therapies like timolol-dorzolamide.
- Further research is warranted to fully understand the fetal effects of antiglaucoma medications during pregnancy.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...